Panacea Biotec Ltd. - Research Center
531349 PANACEABIO Group (B) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
184.00 |
110.08 |
79.98 |
155.52 |
194.68 |
Operating profit |
16.77 |
-78.34 |
-35.82 |
-36.86 |
13.34 |
Interest |
7.01 |
4.68 |
3.35 |
3.69 |
3.77 |
Gross profit |
15.23 |
-68.57 |
-34.22 |
-32.93 |
15.39 |
EPS (Rs) |
0.73 |
-13.23 |
-7.79 |
-7.48 |
0.32 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
5.47 |
14.45 |
4.95 |
7.62 |
5.82 |
Stock adjustment |
-3.45 |
37.38 |
-12.41 |
-48.54 |
6.82 |
Raw material |
74.25 |
66.50 |
38.42 |
133.98 |
36.76 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
42.40 |
34.51 |
37.32 |
35.18 |
27.07 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
54.03 |
50.03 |
52.47 |
71.76 |
110.69 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
10.74 |
12.52 |
13.52 |
12.91 |
13.36 |
Taxation |
- |
- |
- |
- |
0.03 |
Net profit / loss |
4.49 |
-81.09 |
-47.74 |
-45.84 |
1.97 |
Extra ordinary item |
- |
- |
- |
- |
-0.03 |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
6.13 |
6.13 |
6.13 |
6.13 |
6.13 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
9.11 |
-71.17 |
-44.79 |
-23.70 |
6.85 |
GPM (%) |
8.04 |
-55.06 |
-40.29 |
-20.19 |
7.68 |
NPM (%) |
2.37 |
-65.12 |
-56.21 |
-28.10 |
0.98 |